T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$4.01B |
| 2 |
Broadcom
AVGO
|
+$1.49B |
| 3 |
GE Vernova
GEV
|
+$1.19B |
| 4 |
International Paper
IP
|
+$1.05B |
| 5 |
SCHW
Charles Schwab
SCHW
|
+$952M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$2.31B |
| 2 |
Constellation Energy
CEG
|
+$1.94B |
| 3 |
Qualcomm
QCOM
|
+$1.74B |
| 4 |
NVIDIA
NVDA
|
+$1.71B |
| 5 |
Salesforce
CRM
|
+$1.5B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 33.98% |
| 2 | Healthcare | 14.89% |
| 3 | Financials | 10.35% |
| 4 | Consumer Discretionary | 10.11% |
| 5 | Communication Services | 9.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1301
Zentalis Pharmaceuticals
ZNTL
$297M
| $3.78M | ﹤0.01% |
923,901
-2,565,808
| -74% | -$28.7M |
|
|
CIVI
1302
DELISTED
Civitas Resources
CIVI
| $3.77M | ﹤0.01% |
54,665
+1,585
| +3% | +$115K |
|
1303
ONE Gas
OGS
$5.09B
| $3.76M | ﹤0.01% |
58,842
+1,973
| +3% | +$124K |
|
1304
Liberty Global Class C
LBTYK
$3.48B
| $3.75M | ﹤0.01% |
210,244
+39,958
| +23% | +$696K |
|
1305
iShares MSCI EAFE Growth ETF
EFG
$17.4B
| $3.75M | ﹤0.01% |
36,655
+24,655
| +205% | +$2.52M |
|
1306
Americold
COLD
$4.32B
| $3.75M | ﹤0.01% |
146,755
+13,061
| +10% | +$320K |
|
|
CMA
1307
DELISTED
Comerica
CMA
| $3.75M | ﹤0.01% |
73,405
-108,997
| -60% | -$5.57M |
|
1308
Wyndham Hotels & Resorts
WH
$5.51B
| $3.75M | ﹤0.01% |
50,597
+1,677
| +3% | +$121K |
|
1309
Bankunited
BKU
$3.41B
| $3.73M | ﹤0.01% |
127,330
-3,988
| -3% | -$111K |
|
1310
iShares Russell Mid-Cap Value ETF
IWS
$16.1B
| $3.71M | ﹤0.01% |
30,708
| – | – |
|
1311
SoFi Technologies
SOFI
$23.8B
| $3.7M | ﹤0.01% |
560,116
+24,222
| +5% | +$171K |
|
1312
Unity
U
$20.2B
| $3.69M | ﹤0.01% |
226,826
-126,690
| -36% | -$2.71M |
|
1313
Matsons
MATX
$6.39B
| $3.69M | ﹤0.01% |
28,153
+949
| +3% | +$110K |
|
1314
Saic
SAIC
$5.35B
| $3.69M | ﹤0.01% |
31,362
+2,591
| +9% | +$328K |
|
1315
Allison Transmission
ALSN
$10.2B
| $3.68M | ﹤0.01% |
48,439
-47
| -0.1% | -$3.6K |
|
1316
Lear
LEA
$8.16B
| $3.67M | ﹤0.01% |
32,085
-181
| -0.6% | -$23.2K |
|
1317
Jazz Pharmaceuticals
JAZZ
$16B
| $3.64M | ﹤0.01% |
34,140
+1,317
| +4% | +$145K |
|
1318
Kratos Defense & Security Solutions
KTOS
$11.8B
| $3.64M | ﹤0.01% |
182,075
+7,634
| +4% | +$149K |
|
1319
Commerce Bancshares
CBSH
$8.61B
| $3.63M | ﹤0.01% |
71,627
+376
| +0.5% | +$18.6K |
|
1320
TFI International
TFII
$12.1B
| $3.62M | ﹤0.01% |
24,941
+5,972
| +31% | +$843K |
|
1321
MGE Energy Inc
MGEE
$3.06B
| $3.61M | ﹤0.01% |
48,270
-3,808
| -7% | -$297K |
|
1322
Oshkosh
OSK
$9.41B
| $3.6M | ﹤0.01% |
33,244
+1,694
| +5% | +$196K |
|
1323
Hannon Armstrong Sustainable Infrastructure Capital
HASI
$5.44B
| $3.59M | ﹤0.01% |
121,149
+1,058
| +0.9% | +$30.9K |
|
1324
Central Garden & Pet Co Class A
CENTA
$2.41B
| $3.58M | ﹤0.01% |
108,324
+32,062
| +42% | +$1.15M |
|
1325
Arrow Electronics
ARW
$10.6B
| $3.58M | ﹤0.01% |
29,618
+308
| +1% | +$39.4K |
|
Similar funds
T. Rowe Price Associates's Q2 2024 Portfolio in Review
As of Q2 2024, T. Rowe Price Associates held 3,089 positions worth $836B, up 2.4% from $816B the previous quarter. Its ten largest holdings account for 36% of the portfolio.
T. Rowe Price Associates's Q2 2024 filing shows 135 new, 1,850 increased, 836 reduced and 113 closed positions. Its largest new stake was Tempus AI: 5,227,120 shares worth $183M. The largest sale was Microsoft, an estimated $2.31B.
By sector, the portfolio is most concentrated in Technology at 34% of assets, up from 32% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q2 2024 buy was Tempus AI: 5,227,120 shares worth $183M.
- T. Rowe Price Associates added most to Apple in Q2 2024, an estimated $4.01B increase.
- T. Rowe Price Associates's biggest Q2 2024 reduction was Microsoft, cutting an estimated $2.31B.
- T. Rowe Price Associates fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $570M.
- T. Rowe Price Associates's ten largest holdings make up 36% of its $836B portfolio in Q2 2024.
- T. Rowe Price Associates opened 135 new positions and closed 113 in Q2 2024.
- T. Rowe Price Associates's portfolio value rose 2.4% quarter-over-quarter to $836B.
Based on T. Rowe Price Associates's 13F filing for Q2 2024, filed 14 Aug 2024.